Glido M1 Tablet PR
By Glido M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg)

Manufacturer - Endocrine Pharma Pvt Ltd
SURVEY NO43D/1, PLOT NO 3, SHOP NO 1&2, BHAGIRATHI BUILDING, SHREYA NAGAR, NEAR INDUSTRIAL AREA, HUBBALLI , DIST DHARWAD, KARNATAKA

Expires on or after
August, 2025

liver
When it comes to the use of Glido M1 Tablet PR, caution is advised for individuals with liver disease. It may be necessary to adjust the dosage of Glido M1 Tablet PR in such cases, so it is crucial to consult with your doctor before starting the medication. Typically, Glido M1 Tablet PR is initiated at a low dose for patients with mild to moderate liver disease. However, it is not recommended for use in individuals with severe liver disease. It is important to follow your healthcare provider's guidance closely to ensure safe and effective use of this medication.

kidney
Glido M1 Tablet PR should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for guidance.

alcohol
It is not safe to mix alcohol with Glido M1 Tablet PR.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Glido M1 Tablet PR to ensure safety.

pregnancy
Glido M1 Tablet PR may be unsafe during pregnancy. Limited human studies suggest risks to the developing baby. Consult your doctor for a careful assessment of benefits and risks before using this medication.

breastfeeding
Caution Glido M1 Tablet PR is not safe to use while breastfeeding as it may cause toxicity to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹90
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024